SCHEMBL3104684

SCHEMBL3104684

[CH2][C@@H](C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3107782 1.00
SCHEMBL23707 1.00
SCHEMBL21753963 0.96
SCHEMBL29101700 0.96
Magnesium Chloride Anhydrous SCHEMBL29101698 0.87
SCHEMBL29101699 0.87
SCHEMBL17607617 0.83 METAP1 (0.36)
SCHEMBL10526775 0.81 TSHR (0.33)
SCHEMBL1972172 0.81 TSHR (0.46)
SCHEMBL83492 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2888586-A1 SYSTEM AND METHOD FOR DETECTING OF ALPHA-METHYLACYL-COA RACEMASE (AMACR) AND PROSTATE CANCER Case Western Reserve University (US) 2015-07-01 EP claimed
WO-2014032044-A1 SYSTEM AND METHOD FOR DETECTING OF ALPHA-METHYLACYL-COA RACEMASE (AMACR) AND PROSTATE CANCER CASE WESTERN RESERVE UNIVERSITY (US) 2014-02-27 WO claimed
EP-0640142-B1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER (US) 1998-05-20 EP claimed
EP-0640142-A1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1995-03-01 EP claimed
WO-1993019194-A1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1993-09-30 WO claimed
EP-0284176-B1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1993-08-25 EP claimed
EP-0284176-A2 Process for production of avermectins and cultures therefor PFIZER INC. (US) 1988-09-28 EP claimed
US-4767743-A ANTIINFECTION AGENTS PFIZER INC. (US) 1988-08-30 US claimed
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
WO-2023083747-A1 COPOLYCARBONATE AS A SUPPORTING MATERIAL IN 3D PRINTING COVESTRO DEUTSCHLAND AG (DE) 2023-05-19 WO disclosed
EP-3609876-B1 COVALENT SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME UNIV MICHIGAN REGENTS (US) 2022-03-30 EP disclosed
EP-3924393-A1 SINGLE-COMPONENT ADHESIVE COMPOSITIONS Ohio State Innovation Foundation (US) 2021-12-22 EP disclosed
EP-3790389-A1 4-AMINO-6-(1,3-BENZODIOXOLE)PICOLINATES AND THEIR USE AS HERBICIDES Dow AgroSciences LLC (US) 2021-03-17 EP disclosed
EP-3752540-A1 CATALYST SYSTEMS AND PROCESSES FOR POLY ALPHA-OLEFIN HAVING HIGH VINYLIDENE CONTENT ExxonMobil Chemical Patents Inc. (US) 2020-12-23 EP disclosed
EP-0227306-B1 PEPTIDE IMMUNOSTIMULANTS PFIZER INC. (US) 1989-09-13 EP disclosed
US-4828754-A TILT-TYPE CHIRAL SMECTIC PHASE DAINIPPON INK & CHEMICALS, INC. (JP) 1989-05-09 US disclosed
WO-1989003812-A1 CROSS COUPLING OF TITANIUM ORGANYLS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-05-05 WO disclosed
US-4767743-A ANTIINFECTION AGENTS PFIZER INC. (US) 1988-08-30 US disclosed
EP-0227306-A2 Peptide immunostimulants PFIZER INC. (US) 1987-07-01 EP disclosed
EP-0188222-A2 Novel liquid cristalline compounds having substituents DAINIPPON INK AND CHEMICALS, INC. (JP) 1986-07-23 EP disclosed